Page last updated: 2024-10-28

hydroxychloroquine and Hypoxia

hydroxychloroquine has been researched along with Hypoxia in 19 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.

Research Excerpts

ExcerptRelevanceReference
"The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly."5.62Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease. ( Akat, H; Laloglu, F; Orbak, Z, 2021)
" In fact, two of the actually used drugs against SARS-CoV2, such as chloroquine and the combination lopinavir/ritonavir, might determine a QT (the time from the start of the Q wave to the end of the T wave) interval prolongation and they show several interactions with antiarrhythmic drugs and antipsychotic medications, making them prone to an increased risk of developing arrhythmias."5.12COVID-19 and the burning issue of drug interaction: never forget the ECG. ( Cameli, M; Cameli, P; Franchi, F; Mandoli, GE; Menci, D; Mondillo, S; Sciaccaluga, C; Sisti, N; Valente, S, 2021)
"Although coronavirus disease 2019 (COVID-19) predominantly disrupts the respiratory system, there is accumulating experience that the disease, particularly in its more severe manifestations, also affects the cardiovascular system."2.66A current review of COVID-19 for the cardiovascular specialist. ( Bohula, EA; Lang, JP; Morrow, DA; Moura, FA; Siddiqi, HK; Wang, X, 2020)
"The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly."1.62Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease. ( Akat, H; Laloglu, F; Orbak, Z, 2021)
"Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China."1.56Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report. ( Bhatt, PJ; Narayanan, N; Radbel, J, 2020)
"Hydroxychloroquine (HCQ) has its own side effects, some of which are very serious like acute haemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient patients."1.56A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine. ( Clevenbergh, P; De Bels, D; Leemans, S; Mahadeb, B; Maillart, E; Salaouatchi, MT; Van Noten, H; Vandergraesen, T, 2020)
"Key words: Coronavirus disease 2019 (COVID-19), Meningoencephalitis, Pneumonia."1.56A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19). ( Khan, MA, 2020)
"Methemoglobinemia is a rare disorder of the blood in which there is an increase in methemoglobin, which occurs when hemoglobin is present in the oxidized form."1.56Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report. ( Bloom, A; Faisal, H; Gaber, AO, 2020)
"Diffuse alveolar hemorrhage is an uncommon and often fatal condition in children that is characterized by distinct histopathological etiologies."1.51Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis. ( Asseri, AA; Daines, CL; Zeng, Y, 2019)

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (10.53)24.3611
2020's17 (89.47)2.80

Authors

AuthorsStudies
Radbel, J1
Narayanan, N1
Bhatt, PJ1
Juusela, A1
Nazir, M1
Gimovsky, M1
Everaert, BR1
Muylle, J1
Bartholomeus Twickler, T1
Maillart, E1
Leemans, S1
Van Noten, H1
Vandergraesen, T1
Mahadeb, B1
Salaouatchi, MT1
De Bels, D1
Clevenbergh, P1
Lang, JP1
Wang, X1
Moura, FA1
Siddiqi, HK1
Morrow, DA1
Bohula, EA1
Jacquet-Lagrèze, M1
Riad, Z1
Hugon-Vallet, E1
Ferraris, A1
Fellahi, JL1
Mattioli, M1
Fustini, E1
Gennarini, S1
Mehta, SA1
Leonard, J1
Labella, P1
Cartiera, K1
Soomro, I1
Neumann, H1
Montgomery, RA1
Ali, NM1
Hiedra, R1
Lo, KB1
Elbashabsheh, M1
Gul, F1
Wright, RM1
Albano, J1
Azmaiparashvili, Z1
Patarroyo Aponte, G1
Khan, MA2
Choi, NH1
Silver, ES1
Fremed, M1
Liberman, L1
Sciaccaluga, C1
Cameli, M1
Menci, D1
Mandoli, GE1
Sisti, N1
Cameli, P1
Franchi, F1
Mondillo, S1
Valente, S1
Patel, M1
Gangemi, A1
Marron, R1
Chowdhury, J1
Yousef, I1
Zheng, M1
Mills, N1
Tragesser, L1
Giurintano, J1
Gupta, R1
Gordon, M1
Rali, P1
D'Alonso, G1
Fleece, D1
Zhao, H1
Patlakh, N1
Criner, G1
Faisal, H1
Bloom, A1
Gaber, AO1
Rodriguez-Garcia, JL1
Sanchez-Nievas, G1
Arevalo-Serrano, J1
Garcia-Gomez, C1
Jimenez-Vizuete, JM1
Martinez-Alfaro, E1
Brusasco, C1
Corradi, F1
Di Domenico, A1
Raggi, F1
Timossi, G1
Santori, G1
Brusasco, V1
Orbak, Z1
Laloglu, F1
Akat, H1
Asseri, AA1
Zeng, Y1
Daines, CL1
Rajagopala, S1
Singh, N1
Gupta, K1
Gupta, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Tocilizumab: A Therapeutic Cache Against the Treatment of Severe Cases of COVID-19[NCT04560205]Phase 150 participants (Anticipated)Interventional2020-05-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for hydroxychloroquine and Hypoxia

ArticleYear
A current review of COVID-19 for the cardiovascular specialist.
    American heart journal, 2020, Volume: 226

    Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Biomarkers; Card

2020
Left ventricular dysfunction in COVID-19: A diagnostic issue.
    Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3

    Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndro

2020
COVID-19 and the burning issue of drug interaction: never forget the ECG.
    Postgraduate medical journal, 2021, Volume: 97, Issue:1145

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral

2021
Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature.
    Respirology (Carlton, Vic.), 2010, Volume: 15, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; E

2010

Other Studies

15 other studies available for hydroxychloroquine and Hypoxia

ArticleYear
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
    Chest, 2020, Volume: 158, Issue:1

    Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Azi

2020
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
    American journal of obstetrics & gynecology MFM, 2020, Volume: 2, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysi

2020
Emerging cardiological issues during the COVID-19 pandemic.
    European journal of clinical investigation, 2020, Volume: 50, Issue:7

    Topics: Antiviral Agents; Arrhythmias, Cardiac; Betacoronavirus; Coronary Artery Disease; Coronavirus Infect

2020
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
    Infectious diseases (London, England), 2020, Volume: 52, Issue:9

    Topics: Aged; Azithromycin; Betacoronavirus; Blood Transfusion; Continuous Renal Replacement Therapy; Corona

2020
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; C

2020
Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Acute Kidney Injury; Ambulatory Care; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azit

2020
The use of IV vitamin C for patients with COVID-19: a case series.
    Expert review of anti-infective therapy, 2020, Volume: 18, Issue:12

    Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anti

2020
A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:6

    Topics: Anti-Bacterial Agents; Anticoagulants; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus;

2020
COVID-19 reveals Brugada pattern in an adolescent patient.
    Cardiology in the young, 2020, Volume: 30, Issue:11

    Topics: Antiviral Agents; Brugada Syndrome; C-Reactive Protein; Chest Pain; Consanguinity; Cough; COVID-19;

2020
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.
    BMJ open respiratory research, 2020, Volume: 7, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumat

2020
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
    A&A practice, 2020, Volume: 14, Issue:9

    Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Antioxidants; Ascorbic Acid; Betacoron

2020
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
    Rheumatology (Oxford, England), 2021, 01-05, Volume: 60, Issue:1

    Topics: Aged; Antiviral Agents; Azetidines; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinat

2021
Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
    The European respiratory journal, 2021, Volume: 57, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Air Filters; Algorithms; Antibodies, Monoclonal, Humanized; Antirheu

2021
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
    Cardiology in the young, 2021, Volume: 31, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19;

2021
Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis.
    Saudi medical journal, 2019, Volume: 40, Issue:6

    Topics: Acute Disease; Antibodies, Antineutrophil Cytoplasmic; Capillaries; Chest Pain; Child; Female; Hemor

2019